LFC0 Stock Overview
Operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Lifecare ASA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NOK 0.78 |
| 52 Week High | NOK 3.90 |
| 52 Week Low | NOK 0.56 |
| Beta | -0.53 |
| 1 Month Change | 3.73% |
| 3 Month Change | -25.55% |
| 1 Year Change | -60.10% |
| 3 Year Change | -80.38% |
| 5 Year Change | n/a |
| Change since IPO | -79.98% |
Recent News & Updates
Recent updates
Shareholder Returns
| LFC0 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 18.2% | -0.3% | 1.1% |
| 1Y | -60.1% | -9.9% | 16.0% |
Return vs Industry: LFC0 underperformed the German Medical Equipment industry which returned -9.9% over the past year.
Return vs Market: LFC0 underperformed the German Market which returned 16% over the past year.
Price Volatility
| LFC0 volatility | |
|---|---|
| LFC0 Average Weekly Movement | 13.5% |
| Medical Equipment Industry Average Movement | 6.4% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in DE Market | 12.8% |
| 10% least volatile stocks in DE Market | 3.1% |
Stable Share Price: LFC0's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: LFC0's weekly volatility has decreased from 20% to 14% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 34 | Joacim Holter | lifecare.no |
Lifecare ASA, together with its subsidiaries, operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway. The company develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes and for veterinary applications. It also develops and manufactures a nanostrain biosensor, an ultra-small device that measures pressure, temperature, force, or various other performance indicators in live tissue; and medical devices that remove subdermal implants.
Lifecare ASA Fundamentals Summary
| LFC0 fundamental statistics | |
|---|---|
| Market cap | €12.38m |
| Earnings (TTM) | -€6.85m |
| Revenue (TTM) | €803.57k |
Is LFC0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LFC0 income statement (TTM) | |
|---|---|
| Revenue | NOK 9.26m |
| Cost of Revenue | NOK 0 |
| Gross Profit | NOK 9.26m |
| Other Expenses | NOK 88.24m |
| Earnings | -NOK 78.98m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
Aug 20, 2025
| Earnings per share (EPS) | -4.98 |
| Gross Margin | 100.00% |
| Net Profit Margin | -852.52% |
| Debt/Equity Ratio | 0% |
How did LFC0 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/21 01:47 |
| End of Day Share Price | 2025/05/21 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Lifecare ASA is covered by 1 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ludvig Svensson | Carnegie Commissioned Research |